Safety & Efficacy of AlloRx SC® in PTHS Patients

Clinical trial NCT05165017 · UNKNOWN

Trial details

NCT number: NCT05165017
Sponsor: Vitro Biopharma Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pitt Hopkins Syndrome

Start date: 2021-12-01
Primary completion: 2022-12-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.